← Back to news

Markets

Gold Is on the Rise Again. 2 Mining Stocks to Buy Now.

Y

Will XRP (Ripple) Hit $20 Before the End of This Cycle?

Y

A 17-Year-Old With $0 Income Got Approved for $250K. Here’s the Twisted Reason Why.

Y

The Median 401(k) at 60 Is $89,400. It Produces $298 a Month.

Y

Got $100? 1 Artificial Intelligence (AI) Memory ETF to Buy Hand Over Fist

Y

Century-old bakery chain closing nationwide July 4

Y

Kiyosaki Eyes Gold, Silver Rebound as Hormuz Risks Keep Safe-Haven Case Alive

Y

Enhanced Group (ENHA) Secures $50M in Strategic Equity Financing

Y

Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS

Y

Here is Why Vinfast (VFS) is One of the Penny Stocks With Explosive Growth Potential

Y

Grab (GRAB) to Consolidate Superbank Following Increased Shareholding in Indonesia

Y

HIVE’s (HIVE) BUZZ HPC Secures $220M GPU Cloud Contract for Sovereign AI Infrastructure

Y

Is Cosan (CSAN) One of the Penny Stocks With Explosive Growth Potential?

Y

Alvotech (ALVO): 10 Penny Stocks With Explosive Growth Potential

Y

Vizsla Silver (VZLA) Secures $10M Working Capital Facility from FIFOMI for Panuco Project

Y

Mitsubishi Fuso Truck and Bus Corporation Selects Clarivate (CLVT) IPfolio for IP Management

Y

What a $2 Million Dividend Portfolio Actually Pays After Taxes in California

Y

The Best Semiconductor ETF to Buy With $1,000 Right Now

Y

The Median American Paycheck: $1,235 a Week Becomes $850 After Taxes and Deductions

Y

Billionaire Warren Buffett Disciple Warns: Don’t Quit Your Job To Start A New Business, Do This Instead

Y

Iran reportedly closes Strait of Hormuz again, casting shadow over nuclear talks

F

20% of Warren Buffett-led Berkshire Hathaway's $341 Billion Portfolio Is Invested in 1 Stock That's Quietly Trying to Cash in on the AI Boom

Y

Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?

Y

TJX Is a Reliable Off-Price Retailer, But for Investors, Is the Premium Too High?

Y

Wells Fargo new S&P 500 target sends investors clear signal

Y

When You Play Defense With Consumer Staples, Which ETF Should You Own? Funds From State Street and First Trust Offer a Stark Choice.

Y

Target makes its smartest $1 billion investment yet

Y

Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?

Y

State Street or Fidelity: Which Financial ETF Stands Out in 2026?

Y

If I Had to Start Over With $1,000 in Stocks Today, Here's Exactly What I'd Buy

Y

I spent $200K upgrading my elderly parents' home — here's what the IRS actually lets me deduct

Y

IEA Cuts 2026 Oil Demand Outlook Amid Gulf Disruptions, Sees Recovery Taking Shape in 2027

Y

Which Total U.S. Stock Market ETF Is Better: Vanguard or iShares?

Y

2 Industrial Stocks to Buy After the SpaceX IPO

Y

The Global X Robotics & AI ETF (BOTZ): A Solid Way to Play Robotics

Y

Michael Saylor Touts $48 Billion Bitcoin Turnaround, But Can MicroStrategy’s STRC Survive 2026?

Y

Mission Produce Director Acquires $2.1 Million of Shares in Open Market. Does This Make AVO a Buy?

Y

Baby Boomers Have $525,000 Saved for Retirement. They Need $1.6 Million.

Y

My Favorite Rare Earth Stock To Buy For The Next 10 Years

Y

I'm Calling It: GE Vernova (GEV) Is a Buy Before This Catalyst Drops

Y

Forget SpaceX: See This Overlooked AI Stock in Donald Trump’s Portfolio

Y

Prediction: Will Dell Hit $500 This Year?

Y

Prediction: Netflix Will Reach $100 on This Date

Y

Super Micro Jumped More Than 10%. Is the AI Server Maker Finally Turning a Corner?

Y

New research finds a 'collateral gap' in Bitcoin lending

Y

Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?

Y

Google Losing Top AI Executive Is ‘The Most Significant AI Talent Move of the Year.’ Is It Time to Sell Alphabet Stock?

Y

How Much Can a 62-Year-Old Couple With $2.3 Million in Their 401(k) Save With Roth Conversions?

Y

Costco members voice surprising inventory complaint

Y

Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?

Y